Appointment dossier — Endometrial Cancer
Bring this to your appointment. It summarizes what published studies report — it is not medical advice and does not say anything works. Decisions are yours and your care team’s.
Compounds studied in Endometrial Cancer
No studies or cited compounds on file for this cancer yet.
Open recruiting trials (18)
- NCT06943521 · Phase 1 / Phase 2 — A Study of MT-4561 in Patients With Various Advanced Solid Tumors (United States)
- NCT07377734 · Phase 2 — Intrauterine Injection of Type III Collage in FST of EC/AEH (China)
- NCT06840886 · Phase 1 — A Study of PHST001 in Advanced Solid Tumors (United States)
- NCT05819892 · Phase 1 — Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer (United States)
- NCT06771219 · Phase 1 — SLV-154 Treatment of Metastatic Solid Tumors (United States)
- NCT07062016 — Molecular and ctDNA Characterization of High-Risk Endometrial Cancer (United States)
- NCT05051722 — Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer (United States)
- NCT06619002 — Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies (Italy)
- NCT06365905 — Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding (United States)
- NCT07194551 — Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire (Canada)
- NCT06284343 — The Gynecological Cancer Associated Thrombosis (GynCAT) Study (Italy)
- NCT07327489 — Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (United States)
- NCT05179447 — PROfiling Based Endometrial Cancer Adjuvant Therapy (China)
- NCT06800612 — Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers (Italy)
- NCT06339827 — ASk Questions in GYnecologic Oncology (ASQ-GYO) (United States)
- NCT06360653 — a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer (Italy)
- NCT07027046 — Application of da Vinci SP for Endometrial Cancer Surgical Staging (Italy)
- NCT04291612 — Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease (United States)
Most-relevant first: trials that name Endometrial Cancer, then broader trials you may still qualify for. 337 recruiting trials name this cancer on ClinicalTrials.gov. Eligibility is decided by each trial's team — bring these NCT numbers to your appointment.
Questions to ask your oncologist
- Of the open trials I found (for example NCT06943521), am I eligible for any — here or at a larger cancer center?
- What is my exact diagnosis — the type, subtype, stage, and grade?
- Has my tumor had molecular or genomic testing (e.g. next-generation sequencing), and what did it find?
- Should I have inherited (germline) genetic testing, and could it affect my treatment or my family?
- What is the goal of treatment for me — cure, long-term control, or comfort?
- What are all of my standard treatment options, and what does each one involve?
- What is the realistic benefit of each option, in actual numbers?
- What are the most common and the most serious side effects, and how are they managed?
- How will we know if treatment is working, and how often will I be scanned or tested?
- If the first treatment doesn't work, what are the next options?
- Are there gentler options if I want to prioritize quality of life?
- Am I eligible for any clinical trials — here or at a larger/academic cancer center?
- Is my case reviewed by a multidisciplinary tumor board?
- Would a second opinion at a center that treats my cancer often be worthwhile?
- Could any of my prescriptions, over-the-counter drugs, or supplements interfere with treatment?
- Which symptoms are emergencies, and who do I call after hours?
- Should I see palliative or supportive care alongside my treatment?
- How will treatment affect my daily life, work, and (if it matters to me) fertility?
- What can I safely do myself — diet and activity — and is anything I'm taking risky?
- What will treatment cost, and is financial assistance available?
- Should my tumor tissue be stored (biobanked) for future testing or trials?